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TWO DISTINCTIVE BIOLOGICAL TIMING PROCESSES 
INTERACT IN THE CREATION OF A REST-ACTIVITY 
CYCLE - THE CIRCADIAN OSCILLATOR AND THE SLEEP 
homeostat.1 In mammals, the circadian oscillation is driven by 
a negative feedback loop involving the Period (Per1, Per2, 
and Per3) and Cryptochrome (Cry1 and Cry2) genes, whose 
transcription is initiated early in the morning. The translated 
proteins form heteropolymers with each other and with casein 
kinase Iδ (CK1δ and ε (CK1ε),2 which provide the phosphoryla-
tion of specific sites that influence protein stability and nuclear 
translocation.3 In the nucleus, these heteropolymers inhibit the 
positive transcription factors (CLOCK/NPAS2 and BMAL1/2) 
that stimulate Per/Cry transcription, thereby closing the cycle. 
The genetic basis of the sleep homeostat is currently less well 
understood.4 However, many reports of genetic factors involved 
in sleep pertain to clock genes involved in the circadian oscil-
lator, which may affect sleep either via its interaction with the 
sleep homeostat, or via pleiotropic action of clock genes. Thus, 
altered sleep homeostasis has been reported in knockout mice 
lacking both Cry1 and Cry25 or Npas2.6
In a few human pedigrees, altered free-running period is 
seen in mutations that cause the circadian rhythm sleep disorder 
ASPD/ASPS (advanced sleep phase disorder or syndrome). In 
affected individuals, the preferred sleep/wake cycle is advanced 
in relation to the external 24-h cycle by several hours.7 
Mutations causing familial ASPD have been found in the PER28 
and CSNK1D (CK1δ9) genes. Associations with extreme diurnal 
preference, which is a much more easily obtained correlate of 
intrinsic period and sleep timing,10,11 have been reported for 
polymorphisms in CLOCK,12 PER1,13 PER2,14 and PER3.15-17 
In contrast to ASPD, delayed sleep phase disorder/syndrome 
(DSPD/DSPS) is not generally believed to necessarily reflect 
a longer intrinsic period (although this has been reported 
in one case18). Rather, it may be associated with an altered 
phase relationship between the oscillator and the sleep-wake 
cycle and/or abnormal entrainment, and possibly altered sleep 
homeostasis.19 Genetic studies have indicated polymorphisms 
in PER315,17,20 as risk factors for DSPD.
The human PER3 gene is substantially more polymorphic 
than the other PER paralogs21 and does not display signs of 
either positive or balancing selection.22 A series of experiments 
with double knockout mouse models in different combinations 
of the three Per paralogs showed that, unlike Per1 and Per2, 
Per3 is neither necessary nor sufficient to drive circadian 
rhythmicity in the absence of the other two.23 Four haplotypes 
composed of different combinations of five polymorphisms 
affecting the encoded protein sequence were first identified in 
a Japanese population.20 One of these haplotypes was defined 
by the missense polymorphism V647G, and was reported to 
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associate with DSPD. Another polymorphism described but 
not further analyzed in this study was a coding-region variable 
number tandem repeat (VNTR) polymorphism, consisting of an 
18-amino-acid motif repeated 4 or 5 times (PER34 and PER35). 
We have previously reported an association between the PER35 
allele and extreme morning preference, and between the PER34 
allele and extreme evening preference as well as DSPD.15 In 
a subsequent prospective study, PER35/5 homozygotes were 
found to have reduced sleep latency, and spend a substantially 
higher proportion of their sleep time in slow wave sleep 
(SWS).24 When kept awake during the subsequent night, they 
displayed a higher amount of theta activity, and a dramatic 
reduction in cognitive test performance.25 A more recent study 
has confirmed similar effects of the same polymorphism on the 
sleep deprived EEG.26 Thus, the previously reported association 
of the PER3 VNTR with diurnal preference may in fact be a 
reflection not so much of differences in circadian parameters, 
as of the increased amount of sleep pressure experienced 
by PER35/5 homozygotes.27 In other words, as supported by 
the double knockout mouse study,23 Per3 may have a more 
important role in sleep homeostatic mechanisms than in the 
circadian oscillator.
Given the importance of the coding-region polymorphisms 
in the human PER3 gene in influencing diurnal preference and 
as a risk factor for DSPD, we extended our studies into the 
promoter region, for which polymorphisms had not previously 
been reported. We discovered a novel cluster of polymorphisms 
in the PER3 promoter region, provided an improved definition 
of the promoter region itself, and investigated the effect of the 
polymorphism cluster on gene expression.
MATERIALS AND METHODS
Subjects
Horne-Östberg (HÖ)28 diurnal preference scores and buccal 
DNA samples were obtained from a population of 1,590 volun-
teers aged between 18 and 81 years, as described previously.29,16 
Genetic analyses were conducted on the 5% of subjects with 
the highest (extreme morning preference) and the lowest (ex-
treme evening preference) HÖ scores, which were corrected 
for age but not for gender by regression analysis (n = 80 in 
each group). In addition, an equal number of individuals with 
an intermediate HÖ score close to the regression line were se-
lected. A separate group of patients diagnosed with DSPD (n = 
23)13 according to the version of the International Classification 
of Sleep Disorders that was current at the time of diagnosis30 
were also investigated. HÖ scores and demographic data for 
all four groups are shown in Table 1. DNA from each subject 
was extracted as described previously.29,16 All studies were per-
formed in accordance with the Declaration of Helsinki, and had 
received a favorable opinion from the University of Surrey Eth-
ics Committee.
Polymorphism Detection
An approximate definition of the PER3 promoter region was 
obtained by identifying an upstream segment highly conserved 
between the human, rat and mouse genomes, according to the 
Ensembl genome browser. This suggested a region spanning be-
tween the predicted transcriptional start site and nucleotide posi-
tion −874. Screening of the promoter region was performed in 
pools of DNA samples prepared from subjects with extreme di-
urnal preference, as well as from panels of pooled DNA samples 
from specific ethnic groups (Coriell Institute, Camden, NY), 
as previously described.14 The polymorphism cluster identified 
through this process was contained within the amplicon ob-
tained using the primers CGCGGCGCCGGCTGCTGACC and 
TCACCCCTGCCCCAACTTTC and the following amplifica-
tion parameters: 95°C for 4 min, followed by 35 cycles of 95°C 
for 1 min, 63°C for 1 min, and 72°C for 1 min. The PER3 pro-
moter region is highly GC-rich and difficult to amplify by PCR. 
For amplification of this region, the Failsafe system (Epicentre 
Biotechnologies, Madison, WI) was used, identifying buffer pre-
mix E as optimal. Genotyping of all amplicons was conducted 
by direct sequencing (CEQ2000, Beckman Coulter, Fullerton, 
CA). The same conditions were used for genotyping of partici-
pant DNA samples. Some amplicons were cloned using the TA 
Cloning Kit (Promega, Madison, WI) prior to sequencing.
Promoter Expression Constructs
Fragments representing the four different observed promoter 
allelic combinations (PH1–PH4 in Figure 1) (–874 to +130 in 
the canonical sequence) were inserted into the pGL3-Enhancer 
vector (Promega). The existence of these four combinations 
on single chromosomes was confirmed by sequencing of TA-
cloned PCR products amplified from individual participants. 
Vector constructs, including a control vector with no insert, 
were purified using the Pureyield Midiprep system (Promega), 
quantified (NanoDrop ND-1000, NanoDrop Technologies, 
Wilmington, DE), and sequenced using vector-specific primers. 
Prior to transfection and expression, human embryonic kidney 
cells (HEK293) were seeded into 96-well plates (1 × 104 cells/
well) and grown for 48 h in minimum essential medium (Eagle) 
containing 2 mM L-glutamine and Earle’s BSS (basic sodium 
salts), 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino 
acids, supplemented with 10% heat-inactivated horse serum, 
and 1 mM sodium pyruvate (all cell culture reagents from 
Sigma, St. Louis, MO). Then 48 ng of the expression constructs 
were transiently transfected into HEK293 cells using the 
FuGene 6 Transfection Reagent (Roche Applied Science, Basel, 
Switzerland). To normalize the data for transfection efficiency, 2 
ng of a Renilla luciferase vector (pRL-SV40, Promega) was co-
transfected into the same cells. All transfections were completed 
in triplicate and repeated in two or three separate experiments. 
The effects of the putative promoter inserts on the expression 
of the downstream luciferase gene were then quantified by 
measuring luciferase activity after 24 h using the Dual-Glo 
Luciferase Assay System (Promega) and a Lumicount Luminator 
(VICTOR3 Multilabel counter, PerkinElmer, Boston, MA).
Table 1—Circadian phenotype and demographic data for study participants
Group
HÖ score 
(mean ± SD)
Gender ratio 
(female/male)
Age 
(mean ± SD)
Morning 72 ± 7 44/36 37.1 ± 10.6
Evening 30 ± 6 44/36 41.6 ± 16.3
Intermediate 53 ± 4 38/42 41.6 ± 16.3
DSPD N/A 11/12 27.9 ± 14.9
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To further define the PER3 promoter region and 
identify potential enhancer or suppressor elements 
within it, the most frequently occurring allelic com-
bination (PH1) was subjected to nested deletion 
mutagenesis (Erase-a-Base, Promega). The follow-
ing nested deletions were generated with respect to 
the full-length fragment size: 833 (−703 to +130), 
735 (−605 to +130), 413 (−283 to +130), and 210 
(−80 to +130) (numbering in brackets indicates start 
and end positions with respect to the transcriptional 
start site). These deleted fragments were created 
within the pGL3-Enhancer vector, which was re-
ligated, purified, and sequenced. These constructs 
were then used, together with the full-length promoter fragment 
and a control vector with no insert, in the same transfection 
reporter experiment described above. The full-length 1,004-bp 
approximate PER3 promoter region sequence was also ana-
lyzed for the existence of potential transcription factor binding 
sites (TFBS) (MatInspector, Genomatix, Munich, Germany). 
Only predicted TFBS with core and matrix sequence similarity 
values of at least 1.00 and 0.89, respectively, were considered 
(maximum = 1.00 for each).
A two-sided Fisher exact test (Prism 5.0a, GraphPad, La Jol-
la, CA) was used to determine statistical significance of differ-
ences in allele frequencies between subject groups. Bonferroni 
correction for multiple comparisons has been used but because 
there are significant levels of linkage disequilibrium across the 
PER3 gene,31 this is likely to be overly conservative for multiple 
polymorphism analysis.32 The two-sided Fisher exact test was 
also used to test for differences between groups in predicted 
haplotype frequencies. The χ2 statistic was used to test for de-
viation from Hardy-Weinberg equilibrium. One-way ANOVA 
(Bonferroni corrected) was used to determine significant differ-
ences between transfection results.
RESULTS
Promoter Region Polymorphisms
The presence of three promoter region single nucleo-
tide plymorphisms (SNPs) G−320T (rs2797687), C−319A 
(rs2794664), and G−294A (rs228730) was verified in the DNA 
pools and subsequently in individual samples. During the se-
quencing of the amplicons, four individuals were identified 
whose DNA sequence could not be resolved beyond position 
−297, suggesting the heterozygous presence of an insertion or 
deletion polymorphism (indel). To resolve this, the amplicons 
from these individuals were cloned, and individual clones were 
sequenced. This revealed that the promoter region of PER3 
contains a VNTR polymorphism (−318 1/2 VNTR), with one 
or two tandem copies of a 21-bp motif (see Figure, 1). These 
four individuals were heterozygous with alleles containing both 
one and two tandem units, while the remaining participants 
(n = 259) were all homozygous for two units. The genotype and 
allele frequencies for all the promoter polymorphisms in the 
different subject groups are shown in Table 2. Allele frequen-
cies for the G−294A and the −318 1/2 VNTR polymorphisms 
did not differ significantly between any of the subject groups 
studied. The frequencies of the −320T and −319A alleles, how-
ever, were significantly higher in DSPD (T = 0.17, A = 0.17) 
than in extreme morning types (T = 0.07, A = 0.07) (P = 0.042) 
and extreme evening types (T = 0.04, A = 0.06) (P = 0.006 
and 0.033, respectively). Only the difference between DSPD 
patients and evening types with respect to the −320T allele 
remained statistically significant after Bonferroni correction 
(corrected P = 0.024). The −320T and −319A allele frequen-
cies were also significantly higher in the intermediate group 
(T = 0.12, A = 0.19) compared to the evening group (T = 0.04, 
A = 0.06; P = 0.023 and 0.001, respectively), the latter signifi-
cant also after Bonferroni correction with P = 0.004. Intermedi-
ates also showed a higher −319A allele frequency (A = 0.19) 
compared to the morning group (A = 0.07; P = 0.001, P = 0.004 
after Bonferroni correction). The higher −320T and −319A al-
lele frequencies within the intermediate group were due to a 
larger number of heterozygotes for these two SNPs, compared 
to the other subject groups. When the diurnal preference groups 
were combined, the −320T allele (but not the −319A) remained 
significantly higher in the DSPD group (P = 0.046, OR = 2.521, 
95% CI = 1.096 – 5.799). The −318 VNTR was in Hardy-Wein-
berg equilibrium within the subject groups, as was the G−294A 
within the intermediate, evening, and DSPD groups.
When the genotype frequencies were analyzed to predict 
allele combination frequencies (PHASE v2.0.233), four com-
monly occurring haplotypes (predicted frequency 1% or high-
er) were identified, all of which were observed directly through 
cloning and sequencing of amplified genomic DNA. These 
were: GC2G, GC2A, TA2G, and the rare TA1G haplotype, 
which were predicted to occur in the combined diurnal prefer-
ence groups with frequencies of 79%, 10%, 6%, and 1%, re-
spectively. The TA2G combination was predicted to occur more 
in the DSPD group (18%) compared to both morning (6%) and 
evening (3%) groups (P = 0.03, OR = 0.32, 95% CI = 0.12 – 
0.86; P = 0.002, OR = 0.29, 95% CI = 0.10 – 0.81, respectively) 
(Figure 2). The latter remained significant after Bonferroni cor-
rection (P = 0.008).
Analysis of Promoter Activity
The relative induction levels of luciferase activity for the 
four allele combinations in the promoter region, compared 
to a control vector with no insert, are shown in Figure 3. The 
largest induction of gene expression was found with the TA2G 
combination, which was significantly greater than the GC2A 
(P < 0.05) and the TA1G (P < 0.01) combinations. With the se-
rial deletion promoter constructs, significant differences were 
observed in the relative fold induction between the −874/−703 
and the −605/−283 constructs (P < 0.0001), and also between 
Figure 1—Location of the three promoter SNPs genotyped in this study relative to the 
novel 1 or 2 repeat VNTR. The promoter allele combinations PH1 – PH4 are shown, 
together with the aligned sequence from the chimpanzee (release 2.1).
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box) site, as well as bind-
ing sites for: ARNT (aryl 
hydrocarbon receptor 
nuclear translocator) het-
erodimer, NF-κβ (nuclear 
factor-κβ), E4BP4 (ad-
enovirus E4 promoter 
ATF-site binding pro-
tein), PPAR (peroxisome 
proliferators-activated 
receptor), AP-2 (activator 
protein 2), POZ (poxvirus 
and zinc finger) domain, 
MYT1 (myelin transcrip-
tion factor 1) zinc finger 
domain, Sp1 (specific-
ity protein 1), GRE (glu-
cocorticoid response 
element), and SW1/SNF 
complex (Figure 4).
DISCUSSION
We have discovered a 
polymorphic cluster in the 
promoter region of PER3, 
and identified an allelic 
combination that both as-
sociates with DSPD, and 
increases the efficiency of 
the PER3 promoter in a 
reporter gene assay.
The two SNPs in the 
promoter that associate 
with DSPD are immedi-
ately adjacent, and form 
part of a polymorphism 
cluster within the promot-
er region (Figure 1). Im-
mediately following these 
two SNPs is a VNTR 
polymorphism with one 
or two copies of a 21-bp 
unit. The two-unit allele 
is by far the most com-
mon one, and contains 
within it the fourth poly-
morphism of the cluster 
(G−294A). This form is 
found in allelic combina-
tions both with GC and 
with TA in the preceding 
SNPs, whereas we only found the much rarer one-unit VNTR 
allele combined with TA. Interestingly, the chimpanzee se-
quence in Genbank carries the other major human SNP com-
bination, GC, followed by one unit of the VNTR (which one 
would a priori hypothesize to be the ancestral form). This may 
indicate either that the SNPs go back to the common ancestor 
of the two species, in which case the chimpanzee would be pre-
dicted to be polymorphic as well, or that the region is intrinsi-
the −605/−283 constructs and the −80 construct (P < 0.0001) 
(Figure 4).
Transcription Factor Binding Sites
Analysis of the PER3 promoter region sequence predicted 
with a high degree of probability the presence of the follow-
ing TFBS, in addition to others with lower probability values; 
Two E-box sites, a DBPE (D-element binding protein, or D-
Figure 3—Relative induction of luciferase gene 
expression, compared to vector control with no insert, for 
the 4 different allelic combination constructs. N = 9 for 
each construct. P < 0.05 (*), P < 0.01 (**).
Table 2—Genotype and allele frequencies in the extreme morning, intermediate, and extreme evening preference groups 
(n = 80 in each group), and DSPD patients (n = 23) for the four PER3 promoter region polymorphisms.
Genotype frequencies
G-320T C-319A -318 VNTR G-294A
GG GT TT CC CA AA 1/1 1/2 2/2 GG GA AA
Morning 0.93 0.01 0.06 0.93 0.01 0.06 0 0.03 0.97 0.86 0.11 0.03
Intermediate 0.85 0.06 0.09 0.70 0.21 0.09 0 0 1.0 0.86 0.14 0
Evening 0.95 0.01 0.04 0.91 0.05 0.04 0 0.03 0.97 0.74 0.25 0.01
DSPD 0.83 0 0.17 0.83 0 0.17 0 0 1.0 0.83 0.17 0
Allele frequencies
G-320T C-319A -318 VNTR G-294A
G T C A 1 2 G A
Morning 0.93 0.07 0.93 0.07 0.01 0.99 0.92 0.08
Intermediate 0.88 0.12 0.81 0.19 0 1.0 0.93 0.07
Evening 0.96 0.04 0.94 0.06 0.01 0.99 0.86 0.14
DSPD 0.83 0.17 0.83 0.17 0 1.0 0.91 0.09
P values, odds ratio, 95% confidence intervals
M vs I 0.001, 3.26, 1.57-6.74
I vs E 0.023, 2.95, 1.20-7.22 0.001, 3.61, 1.70-7.64
M vs D 0.042, 2.85, 1.07-7.58 0.042, 2.85, 1.07-7.58
E vs D 0.006, 4.60, 1.57-13.48 0.033, 3.16, 1.17-8.55
P values are given for statistically significant comparisons of allele frequencies between morning (M), intermediate (I), 
evening (E), and DSPD (D) groups, followed by odds ratios and 95% confidence intervals.
Figure 2—Predicted frequencies for the TA2G 
haplotype in the extreme morning, intermediate, 
and extreme evening preference groups, and DSPD 
patients. P = 0.033 (*), P = 0.002 (**).
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level of expression, but with little difference in expression be-
tween them (Figure 4). The only cis-acting elements predicted 
to be missing in the shorter fragment were two canonical E-box 
sites. This is an interesting observation, as E-boxes (although 
an almost universal feature of clock gene promoters) are miss-
ing from the mouse Per3 promoter,37 although their presence in 
the human promoter did not appear to influence the amplitude 
of basal expression significantly.
The removal of 98 bp between the −703 and the −605 frag-
ment had a significant effect on levels of reporter expression. 
This sequence contains an NF-κβ binding site. NF-κβ is a gene 
expression enhancer that has been shown to be active in the 
hamster suprachiasmatic nucleus (SCN), where it is involved 
with circadian regulation and entrainment.38 It also shows in-
creased activity in the hypothalamus and cortex of sleep-de-
prived mice,39,40 and its accumulation is associated with sleep 
onset and the activation of sleep-promoting substances.41 This 
is an interesting observation given the link between PER3 and 
sleep homeostasis in humans.24
The reduction from the −605 to the −283 fragment removed 
a large section of sequence that contains the promoter polymor-
phisms, the POZ domain, the E4BP4 site, and four Sp1 sites. 
The E4BP4 site also overlaps a DBPE site, which is conserved 
between humans and mice and has previously been proposed to 
drive mPer3 expression.37 E4BP4 acts as a negative regulator of 
mouse Per2 and is required, together with a non-canonical E-
box, for robust circadian expression of Per2.42,43 The presence 
of two closely spaced non-canonical E-box elements within the 
promoters of human PER1-3 has been reported to be necessary 
cally unstable, so that the same SNPs 
have emerged at least twice.
Analysis of the genotype frequen-
cies predicted four main allelic hap-
lotype combinations, one of which, 
TA2G, was predicted to occur at a sig-
nificantly higher frequency in DSPD 
patients compared to extreme morn-
ing and evening types. If one assumes 
that DSPD is a more extreme form of 
evening preference, then it is unclear 
why this haplotype was not predicted 
to occur more frequently within the 
extreme evening preference group. 
However, as discussed above, DSPD 
cannot necessarily be considered as 
one extreme of a diurnal preference 
spectrum. No significant differences 
were observed for TA2G haplotype 
frequency between the different di-
urnal preference groups. Specific in-
formation about ethnicity was neither 
available for the normal volunteers, 
nor for the DSPD patients. However, 
sampling of both took place either in 
the UK or in the Netherlands, and it 
is therefore unlikely that ethnic dif-
ferences constitute a significant con-
founding factor.
We employed a reporter gene sys-
tem both to investigate the effects of the four allelic combina-
tions of the promoter polymorphisms found in a significant 
number of individuals, and to dissect the function of the dif-
ferent regions of the most common promoter sequence. A sig-
nificant association with the T and A SNP alleles and DSPD 
was found only when combined with the 2-unit VNTR. This 
parallels the finding that the TA2G combination produced a 
level of promoter activation that was significantly higher than 
that of TA1G (Figure 3). The other two allelic combinations, 
GC2G and GC2A, gave intermediate levels of reporter gene 
expression.
The 1,004-bp PER3 upstream region was predicted to con-
tain multiple cis-acting elements for transcription factor binding 
(Figure 4). Sp1 binding sites tend to occur in clusters in GC-rich 
regions, which is consistent with the finding of a cluster of five 
potential sites near the middle of the PER3 promoter fragment. 
These sites were in close proximity to the promoter polymor-
phisms described above. Each VNTR repeat unit contained a pu-
tative binding site for Sp1, which is implicated in the repression 
of mouse Per1 transcription34 and may explain the reduced level 
of expression driven by the TA1G construct. Although it does 
not affect the predicted Sp1 sites, the G−320T and C−319A SNP 
duplex is positioned in the middle of the predicted POZ domain, 
which is disrupted in the TA alleles. Transcriptional repression 
by binding to the POZ domain is known to be mediated by in-
terfering with the DNA binding activity of Sp1 in promoters,35 a 
process that is also methylation-state sensitive.36
In the nested deletions of the approximate PER3 promoter, 
the two largest fragments (−874 and −703) produced the highest 
Figure 4—The table part of the figure shows predicted transcription factor binding sites (TFBS), promoter 
position relative to the transcriptional start site, matrix sequence similarity scores (maximum = 1.00) in 
the different deletion constructs. To the right is shown relative induction of luciferase gene expression, 
compared to the vector control with no insert, for the 5 promoter serial deletion constructs. N = 6 for each 
construct. P < 0.0001 (***).
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for sustaining circadian rhythms in culture.44 The absence of a 
significant difference in expression between the −605 and −283 
fragments may be explained by the simultaneous deletion of 
multiple enhancer and repressor elements, or because they con-
trol rhythmic, as opposed to basal, promoter activity. It is also 
possible that a polymorphism in this region has a stronger effect 
on promoter activation than its absence.
The smallest fragment, with the lowest level of transactiva-
tion, additionally lacks the potential glucocorticoid response 
element (GRE), a binding site for glucocorticoid receptors, 
which appear to be expressed in most tissues except the SCN.45 
Glucocorticoids activate these receptors, which then bind pro-
moter GREs and can either induce or repress gene expression.46 
The synthetic glucocorticoid dexamethasone has been shown 
to induce robust expression of mouse Per gene expression in 
culture, including Per3.47 Thus, it seems likely that the presence 
of a GRE in the PER3 promoter may serve to entrain its expres-
sion in peripheral oscillators.
Thus, we have discovered a novel polymorphic hotspot in 
the promoter region, and provided evidence suggesting that it 
may be important both for gene expression levels and for deter-
mining phenotype within the normal and pathological range of 
diurnal preference. Predicted transcription factor binding sites 
are putative and will need to be verified experimentally. Future 
work will also be required to determine the haplotypic com-
binations between this polymorphic promoter cluster and the 
previously described polymorphisms affecting PER3 protein 
structure, and how these combine to affect phenotype. This will 
be important in understanding more fully the phenotypic asso-
ciations that we have previously described for the PER3 VNTR 
polymorphism.48
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